Heart and neural crest derivatives expressed transcript 2 (HAND2): A novel biomarker for the identification of atypical hyperplasia and type i endometrial carcinoma

Rebecca Buell-Gutbrod, Allison Cavallo, Nita Lee, Anthony Montag, Katja Gwin

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Progesterone inhibits the proliferative growth effects of estrogen in the endometrium and prevents the development of endometrial hyperplasia and Type I adenocarcinoma. The exact mechanism of this action is unknown. The progesteroneinduced helix-loop-helix transcription factor Heart and Neural Crest Derivatives Expressed 2 (Hand2) was recently shown to suppress production of growth factors in the endometrium. In Hand2 knockout mice, continuous proliferation of the endometrium was observed. In this study, archival paraffin-embedded tissue from 56 hysterectomy specimens was examined by immunohistochemistry for the expression and localization of Hand2, estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Diagnoses included disordered proliferative endometrium, simple and complex hyperplasia with or without atypia, and endometrioid adenocarcinoma. Hand2 expression is localized to endometrial stromal nuclei. In benign endometrium, Hand2 expression was moderate to strong (10/11; 91%), with weak Hand2 expression in only 1 case (1/11; 9%). Similar Hand2 expression patterns were observed in disordered proliferative endometrium and simple hyperplasia without atypia, with moderate to strong expression in 91% of cases (10/11) and weak expression in 9% of cases (1/11). In contrast, simple and complex hyperplasia with atypia exhibited moderate to strong Hand2 expression in 8% of cases (1/12) and a loss of expression or weak expression in 92% of cases (11/12). In endometrioid adenocarcinomas, Hand2 expression was absent in all cases (22/22). Hand2 is expressed in the stroma of benign endometrium, but expression is significantly reduced or lost in atypical hyperplasia and endometrioid carcinoma. Thus, the absence of Hand2 expression may be a useful biomarker for atypical hyperplasia and endometrioid carcinoma.

Original languageEnglish (US)
Pages (from-to)65-73
Number of pages9
JournalInternational Journal of Gynecological Pathology
Volume34
Issue number1
DOIs
StatePublished - Jan 14 2015

Fingerprint

Neural Crest
Endometrial Neoplasms
Endometrium
Hyperplasia
Endometrioid Carcinoma
Biomarkers
Endometrial Hyperplasia
Progesterone Receptors
Hysterectomy
Knockout Mice
Estrogen Receptors
Paraffin
Progesterone
Intercellular Signaling Peptides and Proteins
Estrogens
Adenocarcinoma
Transcription Factors
Immunohistochemistry
Growth

Keywords

  • Endometrial carcinoma
  • Endometrial hyperplasia
  • Endometrioid carcinoma
  • Hand2
  • Stromal-epithelial signaling

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynecology

Cite this

Heart and neural crest derivatives expressed transcript 2 (HAND2) : A novel biomarker for the identification of atypical hyperplasia and type i endometrial carcinoma. / Buell-Gutbrod, Rebecca; Cavallo, Allison; Lee, Nita; Montag, Anthony; Gwin, Katja.

In: International Journal of Gynecological Pathology, Vol. 34, No. 1, 14.01.2015, p. 65-73.

Research output: Contribution to journalArticle

@article{7c4de190f749448c9d7dea2efd764ee7,
title = "Heart and neural crest derivatives expressed transcript 2 (HAND2): A novel biomarker for the identification of atypical hyperplasia and type i endometrial carcinoma",
abstract = "Progesterone inhibits the proliferative growth effects of estrogen in the endometrium and prevents the development of endometrial hyperplasia and Type I adenocarcinoma. The exact mechanism of this action is unknown. The progesteroneinduced helix-loop-helix transcription factor Heart and Neural Crest Derivatives Expressed 2 (Hand2) was recently shown to suppress production of growth factors in the endometrium. In Hand2 knockout mice, continuous proliferation of the endometrium was observed. In this study, archival paraffin-embedded tissue from 56 hysterectomy specimens was examined by immunohistochemistry for the expression and localization of Hand2, estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Diagnoses included disordered proliferative endometrium, simple and complex hyperplasia with or without atypia, and endometrioid adenocarcinoma. Hand2 expression is localized to endometrial stromal nuclei. In benign endometrium, Hand2 expression was moderate to strong (10/11; 91{\%}), with weak Hand2 expression in only 1 case (1/11; 9{\%}). Similar Hand2 expression patterns were observed in disordered proliferative endometrium and simple hyperplasia without atypia, with moderate to strong expression in 91{\%} of cases (10/11) and weak expression in 9{\%} of cases (1/11). In contrast, simple and complex hyperplasia with atypia exhibited moderate to strong Hand2 expression in 8{\%} of cases (1/12) and a loss of expression or weak expression in 92{\%} of cases (11/12). In endometrioid adenocarcinomas, Hand2 expression was absent in all cases (22/22). Hand2 is expressed in the stroma of benign endometrium, but expression is significantly reduced or lost in atypical hyperplasia and endometrioid carcinoma. Thus, the absence of Hand2 expression may be a useful biomarker for atypical hyperplasia and endometrioid carcinoma.",
keywords = "Endometrial carcinoma, Endometrial hyperplasia, Endometrioid carcinoma, Hand2, Stromal-epithelial signaling",
author = "Rebecca Buell-Gutbrod and Allison Cavallo and Nita Lee and Anthony Montag and Katja Gwin",
year = "2015",
month = "1",
day = "14",
doi = "10.1097/PGP.0000000000000106",
language = "English (US)",
volume = "34",
pages = "65--73",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Heart and neural crest derivatives expressed transcript 2 (HAND2)

T2 - A novel biomarker for the identification of atypical hyperplasia and type i endometrial carcinoma

AU - Buell-Gutbrod, Rebecca

AU - Cavallo, Allison

AU - Lee, Nita

AU - Montag, Anthony

AU - Gwin, Katja

PY - 2015/1/14

Y1 - 2015/1/14

N2 - Progesterone inhibits the proliferative growth effects of estrogen in the endometrium and prevents the development of endometrial hyperplasia and Type I adenocarcinoma. The exact mechanism of this action is unknown. The progesteroneinduced helix-loop-helix transcription factor Heart and Neural Crest Derivatives Expressed 2 (Hand2) was recently shown to suppress production of growth factors in the endometrium. In Hand2 knockout mice, continuous proliferation of the endometrium was observed. In this study, archival paraffin-embedded tissue from 56 hysterectomy specimens was examined by immunohistochemistry for the expression and localization of Hand2, estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Diagnoses included disordered proliferative endometrium, simple and complex hyperplasia with or without atypia, and endometrioid adenocarcinoma. Hand2 expression is localized to endometrial stromal nuclei. In benign endometrium, Hand2 expression was moderate to strong (10/11; 91%), with weak Hand2 expression in only 1 case (1/11; 9%). Similar Hand2 expression patterns were observed in disordered proliferative endometrium and simple hyperplasia without atypia, with moderate to strong expression in 91% of cases (10/11) and weak expression in 9% of cases (1/11). In contrast, simple and complex hyperplasia with atypia exhibited moderate to strong Hand2 expression in 8% of cases (1/12) and a loss of expression or weak expression in 92% of cases (11/12). In endometrioid adenocarcinomas, Hand2 expression was absent in all cases (22/22). Hand2 is expressed in the stroma of benign endometrium, but expression is significantly reduced or lost in atypical hyperplasia and endometrioid carcinoma. Thus, the absence of Hand2 expression may be a useful biomarker for atypical hyperplasia and endometrioid carcinoma.

AB - Progesterone inhibits the proliferative growth effects of estrogen in the endometrium and prevents the development of endometrial hyperplasia and Type I adenocarcinoma. The exact mechanism of this action is unknown. The progesteroneinduced helix-loop-helix transcription factor Heart and Neural Crest Derivatives Expressed 2 (Hand2) was recently shown to suppress production of growth factors in the endometrium. In Hand2 knockout mice, continuous proliferation of the endometrium was observed. In this study, archival paraffin-embedded tissue from 56 hysterectomy specimens was examined by immunohistochemistry for the expression and localization of Hand2, estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Diagnoses included disordered proliferative endometrium, simple and complex hyperplasia with or without atypia, and endometrioid adenocarcinoma. Hand2 expression is localized to endometrial stromal nuclei. In benign endometrium, Hand2 expression was moderate to strong (10/11; 91%), with weak Hand2 expression in only 1 case (1/11; 9%). Similar Hand2 expression patterns were observed in disordered proliferative endometrium and simple hyperplasia without atypia, with moderate to strong expression in 91% of cases (10/11) and weak expression in 9% of cases (1/11). In contrast, simple and complex hyperplasia with atypia exhibited moderate to strong Hand2 expression in 8% of cases (1/12) and a loss of expression or weak expression in 92% of cases (11/12). In endometrioid adenocarcinomas, Hand2 expression was absent in all cases (22/22). Hand2 is expressed in the stroma of benign endometrium, but expression is significantly reduced or lost in atypical hyperplasia and endometrioid carcinoma. Thus, the absence of Hand2 expression may be a useful biomarker for atypical hyperplasia and endometrioid carcinoma.

KW - Endometrial carcinoma

KW - Endometrial hyperplasia

KW - Endometrioid carcinoma

KW - Hand2

KW - Stromal-epithelial signaling

UR - http://www.scopus.com/inward/record.url?scp=84918802041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918802041&partnerID=8YFLogxK

U2 - 10.1097/PGP.0000000000000106

DO - 10.1097/PGP.0000000000000106

M3 - Article

C2 - 25473755

AN - SCOPUS:84918802041

VL - 34

SP - 65

EP - 73

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 1

ER -